Applied Genetic Technologies (AGTC) Tops Q1 EPS by 1c

Applied Genetic Technologies (NASDAQ: AGTC) reported Q1 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $10.3 million, versus $8.44 million reported last year.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
• COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance